Selected research
Industry Research
Blood & Tissue Kit Industry Research Report 2026
Market perspective
The global Blood & Tissue Kit market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Blood & Tissue Kit is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Blood & Tissue Kit is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Blood & Tissue Kit include QIAGEN, Analytik Jena, Axygen (Corning), Bio-Rad, BioVision, Geneaid, Illumina, Lucigen (Biosearch Technologies) and Macherey-Nagel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Blood & Tissue Kit market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blood & Tissue Kit Market by Company
QIAGEN
Analytik Jena
Axygen (Corning)
Bio-Rad
BioVision
Geneaid
Illumina
Lucigen (Biosearch Technologies)
Macherey-Nagel
Norgen
Omega Bio-tek
Promega
Sigma-Aldrich (Merck)
Zymo Research
MGI Tech Co., Ltd.
Roche
Thermo Fisher Scientific
Blood & Tissue Kit Segment by Type
Buffy Coat
Whole Blood
Plasma or Serum
Blood & Tissue Kit Segment by Application
R&D Organisations
Biotechnology Companies
Blood & Tissue Kit Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood & Tissue Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood & Tissue Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood & Tissue Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Blood & Tissue Kit manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Blood & Tissue Kit by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Blood & Tissue Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Buffy Coat
- Whole Blood
- Plasma or Serum
Applications
- R&D Organisations
- Biotechnology Companies
Companies covered
- QIAGEN
- Analytik Jena
- Axygen (Corning)
- Bio-Rad
- BioVision
- Geneaid
- Illumina
- Lucigen (Biosearch Technologies)
- Macherey-Nagel
- Norgen
- Omega Bio-tek
- Promega
- Sigma-Aldrich (Merck)
- Zymo Research
- MGI Tech Co., Ltd.
- Roche
- Thermo Fisher Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Blood & Tissue Kit Market Size (2021-2032)
- 2.2.2 Global Blood & Tissue Kit Sales (2021-2032)
- 2.2.3 Global Blood & Tissue Kit Market Average Price (2021-2032)
- 2.3 Blood & Tissue Kit by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Buffy Coat
- 2.3.3 Whole Blood
- 2.3.4 Plasma or Serum
- 2.4 Blood & Tissue Kit by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 R&D Organisations
- 2.4.3 Biotechnology Companies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Blood & Tissue Kit Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Blood & Tissue Kit Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Blood & Tissue Kit Revenue of Manufacturers (2021-2026)
- 3.4 Global Blood & Tissue Kit Average Price by Manufacturers (2021-2026)
- 3.5 Global Blood & Tissue Kit Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Blood & Tissue Kit, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Blood & Tissue Kit, Product Type & Application
- 3.8 Global Manufacturers of Blood & Tissue Kit, Established Date
- 3.9 Global Blood & Tissue Kit Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 QIAGEN
- 4.1.1 QIAGEN Company Information
- 4.1.2 QIAGEN Business Overview
- 4.1.3 QIAGEN Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 QIAGEN Blood & Tissue Kit Product Portfolio
- 4.1.5 QIAGEN Recent Developments
- 4.2 Analytik Jena
- 4.2.1 Analytik Jena Company Information
- 4.2.2 Analytik Jena Business Overview
- 4.2.3 Analytik Jena Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Analytik Jena Blood & Tissue Kit Product Portfolio
- 4.2.5 Analytik Jena Recent Developments
- 4.3 Axygen (Corning)
- 4.3.1 Axygen (Corning) Company Information
- 4.3.2 Axygen (Corning) Business Overview
- 4.3.3 Axygen (Corning) Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Axygen (Corning) Blood & Tissue Kit Product Portfolio
- 4.3.5 Axygen (Corning) Recent Developments
- 4.4 Bio-Rad
- 4.4.1 Bio-Rad Company Information
- 4.4.2 Bio-Rad Business Overview
- 4.4.3 Bio-Rad Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bio-Rad Blood & Tissue Kit Product Portfolio
- 4.4.5 Bio-Rad Recent Developments
- 4.5 BioVision
- 4.5.1 BioVision Company Information
- 4.5.2 BioVision Business Overview
- 4.5.3 BioVision Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BioVision Blood & Tissue Kit Product Portfolio
- 4.5.5 BioVision Recent Developments
- 4.6 Geneaid
- 4.6.1 Geneaid Company Information
- 4.6.2 Geneaid Business Overview
- 4.6.3 Geneaid Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Geneaid Blood & Tissue Kit Product Portfolio
- 4.6.5 Geneaid Recent Developments
- 4.7 Illumina
- 4.7.1 Illumina Company Information
- 4.7.2 Illumina Business Overview
- 4.7.3 Illumina Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Illumina Blood & Tissue Kit Product Portfolio
- 4.7.5 Illumina Recent Developments
- 4.8 Lucigen (Biosearch Technologies)
- 4.8.1 Lucigen (Biosearch Technologies) Company Information
- 4.8.2 Lucigen (Biosearch Technologies) Business Overview
- 4.8.3 Lucigen (Biosearch Technologies) Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lucigen (Biosearch Technologies) Blood & Tissue Kit Product Portfolio
- 4.8.5 Lucigen (Biosearch Technologies) Recent Developments
- 4.9 Macherey-Nagel
- 4.9.1 Macherey-Nagel Company Information
- 4.9.2 Macherey-Nagel Business Overview
- 4.9.3 Macherey-Nagel Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Macherey-Nagel Blood & Tissue Kit Product Portfolio
- 4.9.5 Macherey-Nagel Recent Developments
- 4.10 Norgen
- 4.10.1 Norgen Company Information
- 4.10.2 Norgen Business Overview
- 4.10.3 Norgen Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Norgen Blood & Tissue Kit Product Portfolio
- 4.10.5 Norgen Recent Developments
- 4.11 Omega Bio-tek
- 4.11.1 Omega Bio-tek Company Information
- 4.11.2 Omega Bio-tek Business Overview
- 4.11.3 Omega Bio-tek Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Omega Bio-tek Blood & Tissue Kit Product Portfolio
- 4.11.5 Omega Bio-tek Recent Developments
- 4.12 Promega
- 4.12.1 Promega Company Information
- 4.12.2 Promega Business Overview
- 4.12.3 Promega Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Promega Blood & Tissue Kit Product Portfolio
- 4.12.5 Promega Recent Developments
- 4.13 Sigma-Aldrich (Merck)
- 4.13.1 Sigma-Aldrich (Merck) Company Information
- 4.13.2 Sigma-Aldrich (Merck) Business Overview
- 4.13.3 Sigma-Aldrich (Merck) Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Sigma-Aldrich (Merck) Blood & Tissue Kit Product Portfolio
- 4.13.5 Sigma-Aldrich (Merck) Recent Developments
- 4.14 Zymo Research
- 4.14.1 Zymo Research Company Information
- 4.14.2 Zymo Research Business Overview
- 4.14.3 Zymo Research Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Zymo Research Blood & Tissue Kit Product Portfolio
- 4.14.5 Zymo Research Recent Developments
- 4.15 MGI Tech Co., Ltd.
- 4.15.1 MGI Tech Co., Ltd. Company Information
- 4.15.2 MGI Tech Co., Ltd. Business Overview
- 4.15.3 MGI Tech Co., Ltd. Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 MGI Tech Co., Ltd. Blood & Tissue Kit Product Portfolio
- 4.15.5 MGI Tech Co., Ltd. Recent Developments
- 4.16 Roche
- 4.16.1 Roche Company Information
- 4.16.2 Roche Business Overview
- 4.16.3 Roche Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Roche Blood & Tissue Kit Product Portfolio
- 4.16.5 Roche Recent Developments
- 4.17 Thermo Fisher Scientific
- 4.17.1 Thermo Fisher Scientific Company Information
- 4.17.2 Thermo Fisher Scientific Business Overview
- 4.17.3 Thermo Fisher Scientific Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Thermo Fisher Scientific Blood & Tissue Kit Product Portfolio
- 4.17.5 Thermo Fisher Scientific Recent Developments
5 Global Blood & Tissue Kit Market Scenario by Region
- 5.1 Global Blood & Tissue Kit Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Blood & Tissue Kit Sales by Region: 2021-2032
- 5.2.1 Global Blood & Tissue Kit Sales by Region: 2021-2026
- 5.2.2 Global Blood & Tissue Kit Sales by Region: 2027-2032
- 5.3 Global Blood & Tissue Kit Revenue by Region: 2021-2032
- 5.3.1 Global Blood & Tissue Kit Revenue by Region: 2021-2026
- 5.3.2 Global Blood & Tissue Kit Revenue by Region: 2027-2032
- 5.4 North America Blood & Tissue Kit Market Facts & Figures by Country
- 5.4.1 North America Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Blood & Tissue Kit Sales by Country (2021-2032)
- 5.4.3 North America Blood & Tissue Kit Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Blood & Tissue Kit Market Facts & Figures by Country
- 5.5.1 Europe Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Blood & Tissue Kit Sales by Country (2021-2032)
- 5.5.3 Europe Blood & Tissue Kit Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Blood & Tissue Kit Market Facts & Figures by Country
- 5.6.1 Asia Pacific Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Blood & Tissue Kit Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Blood & Tissue Kit Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Blood & Tissue Kit Market Facts & Figures by Country
- 5.7.1 South America Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Blood & Tissue Kit Sales by Country (2021-2032)
- 5.7.3 South America Blood & Tissue Kit Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Blood & Tissue Kit Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Blood & Tissue Kit Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Blood & Tissue Kit Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Blood & Tissue Kit Sales by Type (2021-2032)
- 6.1.1 Global Blood & Tissue Kit Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Blood & Tissue Kit Sales Market Share by Type (2021-2032)
- 6.2 Global Blood & Tissue Kit Revenue by Type (2021-2032)
- 6.2.1 Global Blood & Tissue Kit Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Blood & Tissue Kit Revenue Market Share by Type (2021-2032)
- 6.3 Global Blood & Tissue Kit Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Blood & Tissue Kit Sales by Application (2021-2032)
- 7.1.1 Global Blood & Tissue Kit Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Blood & Tissue Kit Sales Market Share by Application (2021-2032)
- 7.2 Global Blood & Tissue Kit Revenue by Application (2021-2032)
- 7.2.1 Global Blood & Tissue Kit Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Blood & Tissue Kit Revenue Market Share by Application (2021-2032)
- 7.3 Global Blood & Tissue Kit Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Blood & Tissue Kit Value Chain Analysis
- 8.1.1 Blood & Tissue Kit Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Blood & Tissue Kit Production Mode & Process
- 8.2 Blood & Tissue Kit Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Blood & Tissue Kit Distributors
- 8.2.3 Blood & Tissue Kit Customers
9 Global Blood & Tissue Kit Analyzing Market Dynamics
- 9.1 Blood & Tissue Kit Industry Trends
- 9.2 Blood & Tissue Kit Industry Drivers
- 9.3 Blood & Tissue Kit Industry Opportunities and Challenges
- 9.4 Blood & Tissue Kit Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst